GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences Announce Publication in The New England Journal of Medicine of a Phase 3 Study of Epidiolex® (cannabidiol oral solution) in Lennox-Gastaut Syndrome

World News: . []

LONDON and CARLSBAD Calif May 16 2018 GLOBE NEWSWIRE) -- GW Pharmaceuticals plc NasdaqGWPH GW the Company or the Group a biopharmaceutical company focused on discovering developing and commercializing novel therapeut ics fro...

More news and information about GW Pharmaceuticals plc

Published By:

Globe Newswire: 22:00 GMT Wednesday 16th May 2018

Published: .

Search for other references to "pharmaceuticals" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us